
Life science investor putting money into young oncology and genetic disease drug developers

Oslo-based private investment company backing early and later-stage life science businesses

Birk Venture is a private evergreen investment company in Oslo, Norway, focused on turning new technologies into health care businesses. Hans Ivar Robinson founded it in 2010, drawing on long experience in pharmaceuticals and biotech.
Entrepreneurs with technology that meets a clear global medical need and has reached proof of concept. It also wants strong management and a solid financing plan. Deal flow comes from universities, startups, private-sector spin-offs and co-investors.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images — click to enlarge
As of 2026-10-07. Organic ranks only; sponsored placements are never ranks.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Birk Venture.
Similar listings buyers compare against this one.

Life science investor putting money into young oncology and genetic disease drug developers

Seed-stage venture firm backing technical founders whose software reaches the physical world

Investment firm backing privately held small and medium-sized businesses across Central and Eastern Europe

Venture capital firm investing at pre-seed and seed stage, with free tools and writing for founders

Auster Capital Partners

Investment firm run by entrepreneurs and financiers that backs ventures and public equities
Everything here links back to the same verified catalogue. Pick your next stop.